BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22829629)

  • 1. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.
    Otsuru S; Gordon PL; Shimono K; Jethva R; Marino R; Phillips CL; Hofmann TJ; Veronesi E; Dominici M; Iwamoto M; Horwitz EM
    Blood; 2012 Aug; 120(9):1933-41. PubMed ID: 22829629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Marrow Transplantation for Treatment of the Col1a2
    Lee LR; Peacock L; Ginn SL; Cantrill LC; Cheng TL; Little DG; Munns CF; Schindeler A
    Calcif Tissue Int; 2019 Apr; 104(4):426-436. PubMed ID: 30535573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta.
    Jones GN; Moschidou D; Lay K; Abdulrazzak H; Vanleene M; Shefelbine SJ; Polak J; de Coppi P; Fisk NM; Guillot PV
    Stem Cells Transl Med; 2012 Jan; 1(1):70-8. PubMed ID: 23197643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation.
    Li F; Wang X; Niyibizi C
    Stem Cells; 2007 Dec; 25(12):3183-93. PubMed ID: 17823236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of bone marrow mesenchymal stem cells from Osteogenesis Imperfecta patients during osteoblast differentiation.
    Kaneto CM; Pereira Lima PS; Prata KL; Dos Santos JL; de Pina Neto JM; Panepucci RA; Noushmehr H; Covas DT; de Paula FJA; Silva WA
    Eur J Med Genet; 2017 Jun; 60(6):326-334. PubMed ID: 28396251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases.
    Wang X; Li F; Niyibizi C
    Stem Cells; 2006 Aug; 24(8):1869-78. PubMed ID: 16675597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model.
    Pauley P; Matthews BG; Wang L; Dyment NA; Matic I; Rowe DW; Kalajzic I
    Int Orthop; 2014 Sep; 38(9):1955-62. PubMed ID: 24384938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles released from mesenchymal stromal cells stimulate bone growth in osteogenesis imperfecta.
    Otsuru S; Desbourdes L; Guess AJ; Hofmann TJ; Relation T; Kaito T; Dominici M; Iwamoto M; Horwitz EM
    Cytotherapy; 2018 Jan; 20(1):62-73. PubMed ID: 29107738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.
    Gioia R; Panaroni C; Besio R; Palladini G; Merlini G; Giansanti V; Scovassi IA; Villani S; Villa I; Villa A; Vezzoni P; Tenni R; Rossi A; Marini JC; Forlino A
    Stem Cells; 2012 Jul; 30(7):1465-76. PubMed ID: 22511244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
    Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
    Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
    Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI
    Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience.
    Götherström C; Westgren M; Shaw SW; Aström E; Biswas A; Byers PH; Mattar CN; Graham GE; Taslimi J; Ewald U; Fisk NM; Yeoh AE; Lin JL; Cheng PJ; Choolani M; Le Blanc K; Chan JK
    Stem Cells Transl Med; 2014 Feb; 3(2):255-64. PubMed ID: 24342908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
    Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
    BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
    Vanleene M; Saldanha Z; Cloyd KL; Jell G; Bou-Gharios G; Bassett JH; Williams GR; Fisk NM; Oyen ML; Stevens MM; Guillot PV; Shefelbine SJ
    Blood; 2011 Jan; 117(3):1053-60. PubMed ID: 21088133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype.
    Sinder BP; Novak S; Wee NKY; Basile M; Maye P; Matthews BG; Kalajzic I
    Stem Cells; 2020 Apr; 38(4):530-541. PubMed ID: 31859429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial.
    Infante A; Gener B; Vázquez M; Olivares N; Arrieta A; Grau G; Llano I; Madero L; Bueno AM; Sagastizabal B; Gerovska D; Araúzo-Bravo MJ; Astigarraga I; Rodríguez CI
    Clin Transl Med; 2021 Jan; 11(1):e265. PubMed ID: 33463067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta.
    Götherström C; Walther-Jallow L
    Curr Osteoporos Rep; 2020 Aug; 18(4):337-343. PubMed ID: 32710427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
    Sui B; Hu C; Zhang X; Zhao P; He T; Zhou C; Qiu X; Chen N; Zhao X; Jin Y
    Stem Cells Transl Med; 2016 Sep; 5(9):1238-46. PubMed ID: 27365487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex Vivo Expanded Allogeneic Mesenchymal Stem Cells With Bone Marrow Transplantation Improved Osteogenesis in Infants With Severe Hypophosphatasia.
    Taketani T; Oyama C; Mihara A; Tanabe Y; Abe M; Hirade T; Yamamoto S; Bo R; Kanai R; Tadenuma T; Michibata Y; Yamamoto S; Hattori M; Katsube Y; Ohnishi H; Sasao M; Oda Y; Hattori K; Yuba S; Ohgushi H; Yamaguchi S
    Cell Transplant; 2015; 24(10):1931-43. PubMed ID: 25396326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.
    King D; Jarjoura D; McEwen HA; Askew MJ
    J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.